Content
@
https://warpcast.com/~/channel/moz
0 reply
0 recast
0 reaction
Dan Romero
@dwr.eth
You’re welcome. https://x.com/zackkanter/status/1774531094433390673?s=46
15 replies
1 recast
44 reactions
K3🫵👁️
@keith33333.eth
you are welcome? explain what you mean. lmao! have you worked healthcare? or are you a dev? lmao!!!
1 reply
0 recast
0 reaction
Dan Romero
@dwr.eth
US market prices subsidize drug prices for the rest of the world
3 replies
0 recast
0 reaction
K3🫵👁️
@keith33333.eth
sorry homie, this is just a touchy subject for me so i got a little too carried away. put it this way i dont agree with you or the OP. and that is what is great is that we can disagree peacefully 🕊️ 🕊️ 🕊️ 💜 💜 💜
0 reply
0 recast
0 reaction
Murgason
@murgason
Truth is that drug developers have to run expensive studies, pay for expensive manufacturing, and large regulatory, medical, and technical staff for years for many drugs. Problem is that if US isn’t price gouged, companies do not have a market large enough to be profitable.
5 replies
0 recast
0 reaction
K3🫵👁️
@keith33333.eth
Their “RD budget” goes for advertisements and fancy promos. They always use RD to justify these expenses and its just plain false. Plenty of citations for this. I work in healthcare and at large academic research hospitals.
0 reply
0 recast
0 reaction
Murgason
@murgason
It costs close to $100k/patient for an oncology clinical trial, 2-300 for phase 2, 1-2000 for phase 3, ongoing phase 4, market access studies. Easy to reach $500M on just the clinical R&D, doesn’t include preclinical, marketing, staff salaries, and any acquisition/licensing costs
2 replies
0 recast
0 reaction
